Cargando…
Activation of Akt protects cancer cells from growth inhibition induced by PKM2 knockdown
BACKGROUND: PKM2 is an attractive target for cancer therapy, however, for many cancer cells, PKM2 knockdown only leads to a modest impairment of survival and proliferation. It is not known whether PKM2 knockdown rewires cell signaling pathways in these “PKM2 knockdown resistant” cells, and whether t...
Autores principales: | Qin, Xiaodong, Du, Yuping, Chen, Xing, Li, Wuyan, Zhang, Jinghong, Yang, Jinbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4108064/ https://www.ncbi.nlm.nih.gov/pubmed/24735734 http://dx.doi.org/10.1186/2045-3701-4-20 |
Ejemplares similares
-
Knockdown of PKM2 Suppresses Tumor Growth and Invasion in Lung Adenocarcinoma
por: Sun, Hong, et al.
Publicado: (2015) -
Knockdown of PKM2 enhances radiosensitivity of cervical cancer cells
por: Lin, Yanzhu, et al.
Publicado: (2019) -
AKT-induced PKM2 phosphorylation signals for IGF-1-stimulated cancer cell growth
por: Park, Young Soo, et al.
Publicado: (2016) -
Efficacy and mechanism of combination of oxaliplatin with PKM2 knockdown in colorectal cancer
por: Yin, Chenxi, et al.
Publicado: (2020) -
PKM2 is not required for pancreatic ductal adenocarcinoma
por: Hillis, Alissandra L, et al.
Publicado: (2018)